Adios, Papa Grande: Jose Valverde out for now as Tigers closer

Oct. 14, 2012
|

Jose Valverde heads to the Detroit dugout after blowing a four-run lead in the ninth inning of Game 1 of the ALCS. He will not be the Tigers' closer for the time being. / Robert Deutsch, USA TODAY Sports

by Steve Gardner, USA TODAY Sports

by Steve Gardner, USA TODAY Sports

NEW YORK â?? Detroit Tigers manager Jim Leyland and his coaching staff spent a groggy Sunday morning trying to figure out what to do with embattled closer Jose Valverde.

After blowing a four-run lead in the bottom of the ninth in the American League Championship Series opener against the New York Yankees, Valverde will not be on the mound for the Tigers if a save situation arises in GameAntithrombin agents: the new class of anticoagulant and antithrombotic drugs.
Antithrombin drugs represent a wide group of natural agents, recombinant agents equivalent to some of the naturally occurring proteins, and synthetic agents. This group of drugs is characterized by marked structural and functional heterogeneity. Several of these drugs are currently in various phases of development. Argatroban represents the first clinically approved antithrombin agent, which was made available in Japan several years ago. Two recombinant hirudin preparations, Revasc (Novartis) and Refludan (Aventis), are available for postsurgical DVT prophylaxis and alternate anticoagulant use in patients with heparin-induced thrombocytopenia. A synthetic antithrombin agent based on the combined structures of hirudin and antithrombin peptides, hirulog (Bivalirudin), is undergoing clinical trials in cardiovascular indications. Additional studies on the hirudins are being carried out to